CPRIT: Patient Adherence to Lung Cancer Screening
Public ClinicalTrials.gov record NCT06872723. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To understand participants' barriers to lung cancer screening and their experience with scheduling lung cancer screening.
Study identification
- NCT ID
- NCT06872723
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 340 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 20, 2025
- Primary completion
- Feb 27, 2029
- Completion
- Feb 27, 2031
- Last update posted
- Apr 1, 2025
2025 – 2031
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| MD Anderson Cancer Center | Houston | Texas | 77030 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Lung Cancer Screening trials
Other public records listing Lung Cancer Screening. Sorted by last update posted; newest first. Not a recommendation.
- NCT07768046: Multiparametric Lung MRI With Diffusion-Weighted Imaging in Lung-RADS 4 Lesion Characterization Not yet recruiting
- NCT07008664: Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer Recruiting
- NCT07711691: Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+) Not yet recruiting
- NCT07682610: Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Health Services Research Intervention Recruiting
- NCT07682597: Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component Recruiting
- NCT07639255: Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06872723, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 1, 2025 · Synced Jul 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06872723 live on ClinicalTrials.gov.